Ultra-targeted accelerated partial breast irradiation using TARGIT – a cautionary note

Rijiv Sarin

One of the seven ongoing trials of accelerated partial breast irradiation (APBI) has concluded that single-dose intraoperative radiotherapy should be considered as an alternative to protracted whole-breast irradiation. With a median follow up of two years, such conclusions seem premature. Until the risk and pattern of recurrence is reported at longer follow up, APBI should remain experimental.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.


*


UA-77507851-1